These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28105288)

  • 21. Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 Inhibitors.
    Papillon JP; Adams CM; Hu QY; Lou C; Singh AK; Zhang C; Carvalho J; Rajan S; Amaral A; Beil ME; Fu F; Gangl E; Hu CW; Jeng AY; LaSala D; Liang G; Logman M; Maniara WM; Rigel DF; Smith SA; Ksander GM
    J Med Chem; 2015 Jun; 58(11):4749-70. PubMed ID: 25953419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2.
    Sakakibara R; Sasaki W; Onda Y; Yamaguchi M; Ushirogochi H; Hiraga Y; Sato K; Nishio M; Egi Y; Takedomi K; Shimizu H; Ohbora T; Akahoshi F
    J Med Chem; 2018 Jul; 61(13):5594-5608. PubMed ID: 29878770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
    Meyers K; Cogan DA; Burke J; Arenas R; Balestra M; Brown NF; Chen Z; Cerny MA; Clifford HE; Colombo F; Fader L; Frederick KS; Guo X; Goldberg D; Hornberger KR; Kugler S; Lord J; Marshall DR; Moss N; Parmentier JH; Richman JR; Schmenk J; Weldon SM; Yu M; Zhang M
    Bioorg Med Chem Lett; 2018 Mar; 28(5):979-984. PubMed ID: 29254646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys.
    Martin RE; Aebi JD; Hornsperger B; Krebs HJ; Kuhn B; Kuglstatter A; Alker AM; Märki HP; Müller S; Burger D; Ottaviani G; Riboulet W; Verry P; Tan X; Amrein K; Mayweg AV
    J Med Chem; 2015 Oct; 58(20):8054-65. PubMed ID: 26403853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors.
    Liu Y; Wu J; Zhou M; Chen W; Li D; Wang Z; Hornsperger B; Aebi JD; Märki HP; Kuhn B; Wang L; Kuglstatter A; Benz J; Müller S; Hochstrasser R; Ottaviani G; Xin J; Kirchner S; Mohr S; Verry P; Riboulet W; Shen HC; Mayweg AV; Amrein K; Tan X
    J Med Chem; 2020 Jul; 63(13):6876-6897. PubMed ID: 32530624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Aldosterone Synthase (
    Shah WA; Jan A; Khan MA; Saeed M; Rahman N; Zakiullah ; Afridi MS; Khuda F; Akbar R
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.
    Grombein CM; Hu Q; Heim R; Rau S; Zimmer C; Hartmann RW
    Eur J Med Chem; 2015 Jan; 89():597-605. PubMed ID: 25462268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between human aldosterone synthase CYP11B2 (-344T/C) gene polymorphism and antihypertensive response to valsartan in Chinese patients with essential hypertension.
    Ji X; Qi H; Li DB; Liu RK; Zheng Y; Chen HL; Guo JC
    Int J Clin Exp Med; 2015; 8(1):1173-7. PubMed ID: 25785110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1H-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2).
    Roumen L; Peeters JW; Emmen JM; Beugels IP; Custers EM; de Gooyer M; Plate R; Pieterse K; Hilbers PA; Smits JF; Vekemans JA; Leysen D; Ottenheijm HC; Janssen HM; Hermans JJ
    J Med Chem; 2010 Feb; 53(4):1712-25. PubMed ID: 20121113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthase.
    Akram M; Patt M; Kaserer T; Temml V; Waratchareeyakul W; Kratschmar DV; Haupenthal J; Hartmann RW; Odermatt A; Schuster D
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105358. PubMed ID: 30965118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Innovation of novel anti-hypertensive drug(s) that inhibit adrenal aldosterone synthase gene (CYP11B2) expression].
    Sugawara A
    Nihon Yakurigaku Zasshi; 2020; 155(5):319-322. PubMed ID: 32879173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.
    Peter M; Dubuis JM; Sippell WG
    Horm Res; 1999; 51(5):211-22. PubMed ID: 10559665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives.
    Lucas S; Heim R; Ries C; Schewe KE; Birk B; Hartmann RW
    J Med Chem; 2008 Dec; 51(24):8077-87. PubMed ID: 19049427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure.
    Furuzono S; Meguro M; Miyauchi S; Inoue S; Homma T; Yamada K; Tagawa YI; Nara F; Nagayama T
    Eur J Pharmacol; 2017 Jan; 795():58-65. PubMed ID: 27915044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2).
    Bogman K; Schwab D; Delporte ML; Palermo G; Amrein K; Mohr S; De Vera Mudry MC; Brown MJ; Ferber P
    Hypertension; 2017 Jan; 69(1):189-196. PubMed ID: 27872236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorinated aldosterone synthase (CYP11B2)-inhibitors for differential diagnosis between bilateral and unilateral conditions of primary aldosteronism.
    Maier P; Heinze B; Gabor S; Reese S; Hahner S; Schirbel A
    Bioorg Med Chem Lett; 2023 Nov; 96():129501. PubMed ID: 37804995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unequal crossing over between CYP11B2 and CYP11B1 causes 11 β -hydroxylase deficiency in a consanguineous family.
    Xiong Y; Zeng Z; Liang T; Yang P; Lu Q; Yang J; Zhang J; Fang W; Luo P; Hu Y; Zhang M; Zhou D
    J Steroid Biochem Mol Biol; 2023 Oct; 233():106375. PubMed ID: 37572761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.
    Abdel Ghafar MT
    Clin Exp Hypertens; 2019; 41(8):779-786. PubMed ID: 30561227
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacophore Modeling and
    Akram M; Waratchareeyakul W; Haupenthal J; Hartmann RW; Schuster D
    Front Chem; 2017; 5():104. PubMed ID: 29312923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.
    Ye P; Nakamura Y; Lalli E; Rainey WE
    Endocrinology; 2009 Mar; 150(3):1303-9. PubMed ID: 18974272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.